A

Artrya Ltd
ASX:AYA

Watchlist Manager
Artrya Ltd
ASX:AYA
Watchlist
Price: 3.77 AUD 9.28%
Market Cap: 596m AUD

Artrya Ltd
PP&E Gross

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Artrya Ltd
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
A
Artrya Ltd
ASX:AYA
PP&E Gross
AU$1.5m
CAGR 3-Years
-15%
CAGR 5-Years
123%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
4DMedical Ltd
ASX:4DX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pro Medicus Ltd
ASX:PME
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcidion Group Ltd
ASX:ALC
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Artrya Ltd
Glance View

Market Cap
596m AUD
Industry
Health Care

Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-26. The firm is focused on operating diagnostic imaging center. The company is primarily engaged in providing powered image-analysis software for coronary artery disease. Its non-invasive solution, Salix uses artificial intelligence (AI) to produce a 3D image and report that provides an accurate detection of coronary artery disease, including the presence of vulnerable plaque. Salix offers precision medicine for cardiac care. The company enables clinicians to triage patients and identify individuals at high risk of heart attack. The firm's cardiac-health report provides diagnostic support to radiologists and cardiologists.

AYA Intrinsic Value
2.66 AUD
Overvaluation 30%
Intrinsic Value
Price
A

See Also

What is Artrya Ltd's PP&E Gross?
PP&E Gross
1.5m AUD

Based on the financial report for Jun 30, 2025, Artrya Ltd's PP&E Gross amounts to 1.5m AUD.

What is Artrya Ltd's PP&E Gross growth rate?
PP&E Gross CAGR 5Y
123%

Over the last year, the PP&E Gross growth was -17%. The average annual PP&E Gross growth rates for Artrya Ltd have been -15% over the past three years , 123% over the past five years .

Back to Top